RETRACTED: Hospital wireless sensor network coverage and ambroxol hydrochloride in the treatment of mycoplasma pneumonia in children

Abstract

According to the clinical investigation and research, we can know that mycoplasma pneumonia is not a rare primary atypical pneumonia, also known as Eaton pneumonia in community acquired classification.The incidence rate of pneumonia is very high in infants and young children. It is a common disease in pediatrics. The incidence of pneumonia has been increasing in recent years. The main symptoms of the disease are chest tightness and cough. Children with pneumonia will also have low immunity. Through the observation of the clinical efficacy and safety of Azithromycin combined with ambroxol hydrochloride, the researchers concluded that the drug containing a large proportion of ambroxol hydrochloride has a significant effect on the treatment of this kind of pneumonia.On the contrary, if the content of azithromycin in the drug is increased, the clinical therapeutic effect is often reduced, but to a certain extent, it is conducive to reduce the inflammation of children and enhance their immunity.